A new blood test that uses RNA data to identify fibromyalgia has been released by IQuity.
A probable diagnosis of fibromyalgia can be indicated with 2 simple tests in chronic pain patients.
Opioid therapy was shown to improve quality of life in patients with comorbid fibromyalgia and PTSD.
Aerobic exercise appeared to benefit health-related quality of life in patients with fibromyalgia.
As a response to the opioid epidemic, clinicians may be overprescribing gabapentinoids.
Childhood adversity levels are increased in female patients with fibromyalgia and chronic pain.
Although there is currently no gold standard therapy for the treatment of fibromyalgia, a number of medications have shown modest efficacy in managing fibromyalgia-related pain, including pregabalin.
While adherence was improved, health care costs were increased.
A 10-minute application resulted in significant reductions in pain scores.
Even minor improvements in fibromyalgia symptoms, depression, anxiety, and pain can have a significant impact on the quality of life in patients with fibromyalgia.
Transcranial random noise stimulation improved both physical and cognitive symptoms of fibromyalgia.
Significant improvement were observed for sensitivity, depression, and anxiety, among others.
Patients with fibromyalgia had a high prevalence of TRAb positivity compared with control populations in previous studies.
Higher self-regulatory fatigue linked to lower QOL scores relating to physical functioning, role limitations-physical, bodily pain, and general health.
Exercise is known to be beneficial in fibromyalgia management; however few studies have examined its specific effects on fatigue.
A multidisciplinary group reviewed evidence on the pharmacological and non-pharmacological management of fibromyalgia.
Combination of lidocaine with amitriptyline showed no meaningful benefits.
There is still insufficient agreement for clinical decisions and diagnosis.
Fibromyalgia places a substantial burden on both patients and the health care system.
Migraine may exacerbate fibromyalgia symptoms, researchers found.
Disordered sleep has been implicated in the impairment of descending inhibitory pain pathways that may contribute to abnormal pain sensitization present in fibromyalgia.
Despite a greater sleep drive, patients with fibromyalgia struggle to stay asleep.
The appropriate dosage of naltrexone for fibromyalgia patients is still unknown.
The reductions in pain intensity persisted at 1 year.
Comorbid disease types appear to elevate dysfunction in the brain.
New research suggests that fibromyalgia is primarily a peripheral nerve disorder that causes central nervous system sensitization.
Women with fibromyalgia spend less time engaged in light to rigorous physical activity than controls.
A mean of 15 HD-tDCS sessions was found to reduce fibromyalgia pain by 50%.
The study looked at differences between fibromyalgia, lupus, and rheumatoid arthritis.
Those taking opioids are less likely to receive guideline-recommended therapy.
Neurology Advisor Articles
- Clarifying Cardiovascular Risk in Migraine
- Parkinson Disease Symptom Fluctuations Well-Managed With Adaptive Deep Brain Stimulation
- More Evidence Supports Benefits of Cannabidiol for Treatment-Resistant Epilepsy
- Monthly Erenumab Reduces Frequency of Episodic Migraine
- Reduced Risk for Multiple Sclerosis Linked to Greater Sun Exposure
- Tamsulosin Associated With Dementia Risk in Older Patients With BPH
- FDA Approves Blood Test to Assess Concussion
- Gait Difficulty in Parkinson Disease May Be Associated With More Progressive Disease Course
- Tau PET a Useful Biomarker for Alzheimer Disease Risk and Progression
- Multiple Sclerosis Drug Zinbryta Withdrawn From the Market
- Incidence of Delayed Traumatic Intracranial Hemorrhage Low in Older Adults With Blunt Head Trauma
- Older Epilepsy Patients More Likely to Experience AED, Non-AED Drug Interaction
- Female Gender, Natalizumab Exposure Associated With Increased Lymphopenia Risk in FNG-Treated MS
- Accelerated Cognitive Decline Associated With Retinopathy
- Treatment Effects Often Exaggerated in Early Clinical Studies